Match!

Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler.

Published on Nov 1, 2013in Cell Metabolism22.415
· DOI :10.1016/j.cmet.2013.10.004
Rachel J. Perry18
Estimated H-index: 18
(Yale University),
Taehan Kim5
Estimated H-index: 5
(Yale University)
+ 9 AuthorsGerald I. Shulman144
Estimated H-index: 144
Sources
Abstract
Summary Nonalcoholic fatty liver disease (NAFLD) affects one in three Americans and is a major predisposing condition for the metabolic syndrome and type 2 diabetes (T2D). We examined whether a functionally liver-targeted derivative of 2,4-dinitrophenol (DNP), DNP-methyl ether (DNPME), could safely decrease hypertriglyceridemia, NAFLD, and insulin resistance without systemic toxicities. Treatment with DNPME reversed hypertriglyceridemia, fatty liver, and whole-body insulin resistance in high-fat-fed rats and decreased hyperglycemia in a rat model of T2D with a wide therapeutic index. The reversal of liver and muscle insulin resistance was associated with reductions in tissue diacylglycerol content and reductions in protein kinase C epsilon (PKCe) and PKCθ activity in liver and muscle, respectively. These results demonstrate that the beneficial effects of DNP on hypertriglyceridemia, fatty liver, and insulin resistance can be dissociated from systemic toxicities and suggest the potential utility of liver-targeted mitochondrial uncoupling agents for the treatment of hypertriglyceridemia, NAFLD, metabolic syndrome, and T2D.
Figures & Tables
  • References (19)
  • Citations (95)
📖 Papers frequently viewed together
201541.06Science
112 Citations
5 Authors (Hanlin Tao, ..., Shengkan Jin)
104 Citations
957 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References19
Newest
#1Derek M. Erion (Yale University)H-Index: 21
#2Violetta Popov (Yale University)H-Index: 1
Last. Varman T. Samuel (Yale University)H-Index: 48
view all 16 authors...
By 2030, nearly half of Americans will have nonalcoholic fatty liver disease. In part, this epidemic is fueled by the increasing consumption of caloric sweeteners coupled with an innate capacity to convert sugar into fat via hepatic de novo lipogenesis. In addition to serving as substrates, monosaccharides also increase the expression of key enzymes involved in de novo lipogenesis via the carbohydrate response element-binding protein (ChREBP). To determine whether ChREBP is a potential therapeut...
41 CitationsSource
#1Donna L. White (BCM: Baylor College of Medicine)H-Index: 21
#2Fasiha Kanwal (BCM: Baylor College of Medicine)H-Index: 42
Last. Hashem B. El-Serag (BCM: Baylor College of Medicine)H-Index: 101
view all 3 authors...
Background & Aims Nonalcoholic fatty liver disease (NAFLD) has been implicated as a cause of hepatocellular carcinoma (HCC). We performed a systematic review of epidemiology studies to confirm the association between these disorders. Methods We searched PubMed for original reports published from January 1992 to December 2011 that evaluated the association between NAFLD, nonalcoholic steatohepatitis (NASH), cryptogenic cirrhosis presumed to be NASH-related, and the risk of HCC. Studies were categ...
345 CitationsSource
#1Varman T. Samuel (Yale University)H-Index: 48
#2Gerald I. Shulman (Yale University)H-Index: 144
Insulin resistance is a complex metabolic disorder that defies explanation by a single etiological pathway. Accumulation of ectopic lipid metabolites, activation of the unfolded protein response (UPR) pathway, and innate immune pathways have all been implicated in the pathogenesis of insulin resistance. However, these pathways are also closely linked to changes in fatty acid uptake, lipogenesis, and energy expenditure that can impact ectopic lipid deposition. Ultimately, these cellular changes m...
1,152 CitationsSource
#1Hui-Young Lee (Yale University)H-Index: 19
#2Andreas L. Birkenfeld (Yale University)H-Index: 22
Last. Gerald I. Shulman (Yale University)H-Index: 144
view all 16 authors...
Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be associated with increased plasma concentrations of apolipoprotein CIII (APOC3) in humans carrying single nucleotide polymorphisms within the insulin response element of the APOC3 gene. To examine whether increased expression of APOC3 would predispose mice to NAFLD and hepatic insulin resistance, human APOC3 overexpressing (ApoC3Tg) mice were metabolically phenotyped following either a regular chow or h...
80 CitationsSource
#1Tiago C. Alves (Yale University)H-Index: 13
#2Douglas E. Befroy (Yale University)H-Index: 24
Last. Gerald I. ShulmanH-Index: 144
view all 8 authors...
Pyruvate dehydrogenase plays a critical role in the regulation of hepatic glucose and fatty acid oxidation; however, surprisingly little is known about its regulation in vivo. In this study we examined the individual effects of insulin and substrate availability on the regulation of pyruvate dehydrogenase flux (VPDH) to tricarboxylic acid flux (VTCA) in livers of awake rats with lipid-induced hepatic insulin resistance. VPDH/VTCA flux was estimated from the [4-13C]glutamate/[3-13C]alanine enrich...
24 CitationsSource
#1Zane B. AndrewsH-Index: 36
#2Zhong-Wu LiuH-Index: 23
Last. Sabrina Diano (Yale University)H-Index: 49
view all 14 authors...
The gut-derived hormone ghrelin exerts its effect on the brain by regulating neuronal activity. Ghrelin-induced feeding behaviour is controlled by arcuate nucleus neurons that co-express neuropeptide Y and agouti-related protein (NPY/AgRP neurons). However, the intracellular mechanisms triggered by ghrelin to alter NPY/AgRP neuronal activity are poorly understood. Here we show that ghrelin initiates robust changes in hypothalamic mitochondrial respiration in mice that are dependent on uncoupling...
519 CitationsSource
#1Cheol Soo Choi (Yale University)H-Index: 43
#2David B. Savage (Yale University)H-Index: 51
Last. Gerald I. Shulman (Yale University)H-Index: 144
view all 14 authors...
Acetyl–CoA carboxylase 2 (ACC)2 is a key regulator of mitochondrial fat oxidation. To examine the impact of ACC2 deletion on whole-body energy metabolism, we measured changes in substrate oxidation and total energy expenditure in Acc2−/− and WT control mice fed either regular or high-fat diets. To determine insulin action in vivo, we also measured whole-body insulin-stimulated liver and muscle glucose metabolism during a hyperinsulinemic–euglycemic clamp in Acc2−/− and WT control mice fed a high...
258 CitationsSource
#1Varman T. SamuelH-Index: 48
#2Zhen-Xiang LiuH-Index: 19
Last. Gerald I. ShulmanH-Index: 144
view all 10 authors...
Nonalcoholic fatty liver disease is strongly associated with hepatic insulin resistance and type 2 diabetes mellitus, but the molecular signals linking hepatic fat accumulation to hepatic insulin resistance are unknown. Three days of high-fat feeding in rats results specifically in hepatic steatosis and hepatic insulin resistance. In this setting, PKCe, but not other isoforms of PKC, is activated. To determine whether PKCe plays a causal role in the pathogenesis of hepatic insulin resistance, we...
350 CitationsSource
#1E KleinerDavidH-Index: 84
#2Elizabeth M. Brunt (SLU: Saint Louis University)H-Index: 73
Last. Arun J. Sanyal (MCV: VCU Medical Center)H-Index: 102
view all 13 authors...
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic steatohepatitis (NASH) is the progressive form of NAFLD. The Pathology Committee of the NASH Clinical Research Network designed and validated a histological feature scoring system that addresses the full spectrum of lesions of NAFLD and proposed a NAFLD activity score (NAS) for use in clinical trials. The scoring system c...
4,774 CitationsSource
#1Kitt Falk Petersen (Yale University)H-Index: 59
#2Sylvie DufourH-Index: 58
Last. Gerald I. ShulmanH-Index: 144
view all 6 authors...
To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used 1 H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6- 2 H 2 ]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were st...
629 CitationsSource
Cited By95
Newest
Source
#1Christopher L. Axelrod (Pennington Biomedical Research Center)
#1Christopher L. Axelrod (Pennington Biomedical Research Center)H-Index: 2
Last. Kyle L. Hoehn (UNSW: University of New South Wales)H-Index: 23
view all 24 authors...
Obesity is a leading cause of preventable death worldwide. Despite this, current strategies for the treatment of obesity remain ineffective at achieving long-term weight control. This is due, in part, to difficulties in identifying tolerable and efficacious small molecules or biologics capable of regulating systemic nutrient homeostasis. Here, we demonstrate that BAM15, a mitochondrially targeted small molecule protonophore, stimulates energy expenditure and glucose and lipid metabolism to prote...
Source
#1Chang-hua Zhang (JUTCM: Jiangxi University of Traditional Chinese Medicine)H-Index: 1
#2Bu-gao Zhou (JUTCM: Jiangxi University of Traditional Chinese Medicine)
Last. Chen Chen (UQ: University of Queensland)H-Index: 55
view all 6 authors...
Abstract The prevalence of nonalcoholic fatty liver disease (NAFLD) in the general population is estimated at 25%, and there is currently no effective treatment of NAFLD. Although insulin resistance (IR) is not the only factor causing the pathogenesis of NAFLD, hepatic IR has a cause-effective relationship with NAFLD. Recovering insulin sensitivity is a potential therapeutic strategy to treat NAFLD. This review highlights the molecular mechanisms of hepatic IR in the development of NAFLD. Availa...
Source
#1Qilin Yu (Technology College)H-Index: 14
#2Guizhu Wu (NKU: Nankai University)H-Index: 1
Last. Pedro J. J. Alvarez (Rice University)H-Index: 73
view all 8 authors...
Targeting specific cellular organelles is an elusive therapeutic goal that could be achieved by manipulating nanocrystal facets. As proof of concept, different facet-engineered nanonods (high-energy (001) CdS and (001) CdSe, and low-energy (101) CdS and (110) CdSe)) exploited selective binding by organelle-targeting peptides and subsequent intracellular protein sorting to inhibit specific organelles without significant cytotoxicity.
Source
#1Stephanie J. Alexopoulos (UNSW: University of New South Wales)H-Index: 1
#2Sing-Young Chen (UNSW: University of New South Wales)
Last. Ashleigh M. Philp (Garvan Institute of Medical Research)
view all 22 authors...
Obesity is a health problem affecting more than 40% of US adults and 13% of the global population. Anti-obesity treatments including diet, exercise, surgery and pharmacotherapies have so far failed to reverse obesity incidence. Herein, we target obesity with a pharmacotherapeutic approach that decreases caloric efficiency by mitochondrial uncoupling. We show that a recently identified mitochondrial uncoupler BAM15 is orally bioavailable, increases nutrient oxidation, and decreases body fat mass ...
Source
#1Chongshu Jian (WHU: Wuhan University)
#2Jiajun Fu (WHU: Wuhan University)H-Index: 1
Last. Rufang Liao (WHU: Wuhan University)H-Index: 1
view all 19 authors...
Summary Nonalcoholic steatohepatitis (NASH) is becoming one of the leading causes of hepatocellular carcinoma (HCC). Sorafenib is the only first-line therapy for advanced HCC despite its serious adverse effects. Here, we report that at an equivalent of approximately one-tenth the clinical dose for HCC, sorafenib treatment effectively prevents the progression of NASH in both mice and monkeys without any observed significant adverse events. Mechanistically, sorafenib’s benefit in NASH is independe...
Source
#1Heidi Coia (GUMC: Georgetown University Medical Center)
#2Ning Ma (GUMC: Georgetown University Medical Center)
Last. Yichen Lee (Georgetown University)
view all 13 authors...
Summary Background & aims Obesity is a major cause of non-alcoholic fatty liver disease (NAFLD). NAFLD is an epidemic affecting nearly 34% of the adult population in the US. As a chronic inflammatory disease, NAFLD influences the immune system by dysregulating T-cell activity. Remedies for the adverse effects on the immune system are urgently needed. We studied Theaphenon E (TE), a standardized formulation of green tea extract, on the adverse effects of NAFLD in C57BL/6J mice fed a high fat diet...
Source
#1Y. E. Yegorov (EIMB: Engelhardt Institute of Molecular Biology)H-Index: 2
The free radical theory of aging was proposed in 1956. Although it does not fully describe the mechanisms of aging, it is generally accepted that reactive oxygen species (ROS) are one of the pathogenetic factors in aging and, in particular, in the development of pathologies associated with aging. The main source of ROS in the cell is mitochondria. Antioxidants directed to mitochondria have a positive effect, but have low efficiency. The problem is that increased amounts of antioxidants disrupt n...
Source
#1Jacob H. Murray (VT: Virginia Tech)
#2Stefan R. Hargett (UVA: University of Virginia)H-Index: 6
Last. Webster L. Santos (VT: Virginia Tech)H-Index: 23
view all 4 authors...
Abstract Mitochondrial protonophores transport protons through the mitochondrial inner membrane into the matrix to uncouple nutrient oxidation from ATP production thereby decreasing the proton motive force. Mitochondrial uncouplers have beneficial effects of decrease reactive oxygen species generation and have the potential for treating diseases such as obesity, neurodegenerative diseases, non-alcoholic fatty liver disease (NAFLD), diabetes, and many others. In this study, we report the structur...
Source
Overnutrition and sedentary activity reinforce the growing trend of worldwide obesity, insulin resistance, and type 2 diabetes. However, we have limited insight into how food intake generates the complex metabolic perturbations associated with obesity. Accumulation of mitochondrial oxidative stress contributes to the metabolic changes in obesity, but the mechanisms and significance are unclear. In white adipose tissue (WAT), mitochondrial oxidative stress and the generation of reactive oxygen sp...
2 CitationsSource